Concepedia

René Swanink

RS

15

Publications

1.7K

Citations

14

H-Index

2004

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Belgium)

Otsuka (United States)

Innsbruck Medical University

Dana-Farber Cancer Institute

René Swanink is an author at Bristol-Myers Squibb (United States) specializing in medicine, psychopharmacology, and psychiatry.

Top concepts

Publications per year

2004–2021

15

Publications

15

The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder

Robert Berman, Ronald N. Marcus, René Swanink et al. · The Journal of Clinical Psychiatry · 2007 · 402 citations

Aripiprazole Augmentation in Major Depressive Disorder: <i>A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants</i>

Robert Berman, Maurizio Fava, Michael E. Thase et al. · CNS Spectrums · 2009 · 256 citations

Effectiveness of aripiprazole v. Haloperidol in acute bipolar mania

Eduard Vieta, Michel Bourin, Raymond Sanchez et al. · The British Journal of Psychiatry · 2005 · 173 citations · Full text

Aripiprazole for the Treatment of Psychoses in Institutionalized Patients With Alzheimer Dementia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Assessment of Three Fixed Doses

Jacobo Mintzer, Larry E. Tune, Christopher D. Breder et al. · American Journal of Geriatric Psychiatry · 2007 · 157 citations

, , +15

Aripiprazole for the Treatment of Psychosis in Patients With Alzheimer's Disease

Peter Paul De Deyn, Dilip V. Jeste, René Swanink et al. · Journal of Clinical Psychopharmacology · 2005 · 150 citations

, , +16

Rows per page

1–5 of 15